Dialan, Ganiel A.
HRN: 19-58-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/30/2023
05/16/2023
IV
1.5g
Q6Hrs
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes